Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors
Cancer is one of the major causes of death worldwide. Its treatments usually fail when the tumor has become malignant and metastasized. Metastasis is a key source of cancer recurrence, which often leads to resistance towards chemotherapeutic agents. Hence, most cancer-related deaths are linked to th...
Published in: | Journal of Oncology |
---|---|
Main Author: | |
Format: | Review |
Language: | English |
Published: |
Hindawi Limited
2022
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85130745213&doi=10.1155%2f2022%2f3249766&partnerID=40&md5=442409d52a50085f42c7b2e1d3ef5e3f |
id |
2-s2.0-85130745213 |
---|---|
spelling |
2-s2.0-85130745213 Tune B.X.J.; Sim M.S.; Poh C.L.; Guad R.M.; Woon C.K.; Hazarika I.; Das A.; Gopinath S.C.B.; Rajan M.; Sekar M.; Subramaniyan V.; Fuloria N.K.; Fuloria S.; Batumalaie K.; Wu Y.S. Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors 2022 Journal of Oncology 2022 10.1155/2022/3249766 https://www.scopus.com/inward/record.uri?eid=2-s2.0-85130745213&doi=10.1155%2f2022%2f3249766&partnerID=40&md5=442409d52a50085f42c7b2e1d3ef5e3f Cancer is one of the major causes of death worldwide. Its treatments usually fail when the tumor has become malignant and metastasized. Metastasis is a key source of cancer recurrence, which often leads to resistance towards chemotherapeutic agents. Hence, most cancer-related deaths are linked to the occurrence of chemoresistance. Although chemoresistance can emerge through a multitude of mechanisms, chemoresistance and metastasis share a similar pathway, which is an epithelial-to-mesenchymal transition (EMT). Matrix metalloproteinases (MMPs), a class of zinc and calcium-chelated enzymes, are found to be key players in driving cancer migration and metastasis through EMT induction. The aim of this review is to discuss the regulatory roles and associated molecular mechanisms of specific MMPs in regulating chemoresistance, particularly EMT initiation and resistance to apoptosis. A brief presentation on their potential diagnostic and prognostic values was also deciphered. It also aimed to describe existing MMP inhibitors and the potential of utilizing other strategies to inhibit MMPs to reduce chemoresistance, such as upstream inhibition of MMP expressions and MMP-responsive nanomaterials to deliver drugs as well as epigenetic regulations. Hence, manipulation of MMP expression can be a powerful tool to aid in treating patients with chemo-resistant cancers. However, much still needs to be done to bring the solution from bench to bedside. © 2022 Bernadette Xin Jie Tune et al. Hindawi Limited 16878450 English Review All Open Access; Gold Open Access |
author |
Tune B.X.J.; Sim M.S.; Poh C.L.; Guad R.M.; Woon C.K.; Hazarika I.; Das A.; Gopinath S.C.B.; Rajan M.; Sekar M.; Subramaniyan V.; Fuloria N.K.; Fuloria S.; Batumalaie K.; Wu Y.S. |
spellingShingle |
Tune B.X.J.; Sim M.S.; Poh C.L.; Guad R.M.; Woon C.K.; Hazarika I.; Das A.; Gopinath S.C.B.; Rajan M.; Sekar M.; Subramaniyan V.; Fuloria N.K.; Fuloria S.; Batumalaie K.; Wu Y.S. Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors |
author_facet |
Tune B.X.J.; Sim M.S.; Poh C.L.; Guad R.M.; Woon C.K.; Hazarika I.; Das A.; Gopinath S.C.B.; Rajan M.; Sekar M.; Subramaniyan V.; Fuloria N.K.; Fuloria S.; Batumalaie K.; Wu Y.S. |
author_sort |
Tune B.X.J.; Sim M.S.; Poh C.L.; Guad R.M.; Woon C.K.; Hazarika I.; Das A.; Gopinath S.C.B.; Rajan M.; Sekar M.; Subramaniyan V.; Fuloria N.K.; Fuloria S.; Batumalaie K.; Wu Y.S. |
title |
Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors |
title_short |
Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors |
title_full |
Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors |
title_fullStr |
Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors |
title_full_unstemmed |
Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors |
title_sort |
Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors |
publishDate |
2022 |
container_title |
Journal of Oncology |
container_volume |
2022 |
container_issue |
|
doi_str_mv |
10.1155/2022/3249766 |
url |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85130745213&doi=10.1155%2f2022%2f3249766&partnerID=40&md5=442409d52a50085f42c7b2e1d3ef5e3f |
description |
Cancer is one of the major causes of death worldwide. Its treatments usually fail when the tumor has become malignant and metastasized. Metastasis is a key source of cancer recurrence, which often leads to resistance towards chemotherapeutic agents. Hence, most cancer-related deaths are linked to the occurrence of chemoresistance. Although chemoresistance can emerge through a multitude of mechanisms, chemoresistance and metastasis share a similar pathway, which is an epithelial-to-mesenchymal transition (EMT). Matrix metalloproteinases (MMPs), a class of zinc and calcium-chelated enzymes, are found to be key players in driving cancer migration and metastasis through EMT induction. The aim of this review is to discuss the regulatory roles and associated molecular mechanisms of specific MMPs in regulating chemoresistance, particularly EMT initiation and resistance to apoptosis. A brief presentation on their potential diagnostic and prognostic values was also deciphered. It also aimed to describe existing MMP inhibitors and the potential of utilizing other strategies to inhibit MMPs to reduce chemoresistance, such as upstream inhibition of MMP expressions and MMP-responsive nanomaterials to deliver drugs as well as epigenetic regulations. Hence, manipulation of MMP expression can be a powerful tool to aid in treating patients with chemo-resistant cancers. However, much still needs to be done to bring the solution from bench to bedside. © 2022 Bernadette Xin Jie Tune et al. |
publisher |
Hindawi Limited |
issn |
16878450 |
language |
English |
format |
Review |
accesstype |
All Open Access; Gold Open Access |
record_format |
scopus |
collection |
Scopus |
_version_ |
1809678158506491904 |